S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

DRUG Bright Minds Biosciences Inc

35.90

0.00 (0.00%)

07 Mar 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Bright Minds Biosciences (NASDAQ:DRUG)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Bright Minds Biosciences Charts.

Bright Minds Biosciences (NASDAQ:DRUG)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Bright Minds Biosciences Charts.

Bright Minds Biosciences Inc News

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research
Wednesday 5 March 2025 (3 days ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 25 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
Monday 24 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Tuesday 18 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Saturday 15 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form F-3 - Registration statement by foreign private issuers
Wednesday 5 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer
Tuesday 7 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 22 November 2024 (3 months ago) • Edgar (US Regulatory)

Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
Friday 22 November 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 6 November 2024 (4 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 6 November 2024 (4 months ago) • Edgar (US Regulatory)

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
Tuesday 5 November 2024 (4 months ago) • GlobeNewswire Inc.

More Bright Minds Biosciences Inc News Articles

Gold vs US Dollar

Newcrest Mining

Australian SE All Ordina...

National Australia Bank

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions